Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for O'Neill Gilmore Neil

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-03-02
Option Award
2023-03-06
4:30 pm
N/A
2033-03-01
Editas Medicine Inc.EDITO'Neill Gilmore Neil
CEO
200,000$0286,655
(Direct)
View
2022-06-24
Option Award
2022-06-27
6:10 pm
N/A
2032-06-23
Unity Biotechnology Inc.UBXO'Neill Gilmore Neil
Director
25,000$025,000
(Direct)
View
2022-06-02
Option Award
2022-06-06
4:44 pm
N/A
2032-06-01
Editas Medicine Inc.EDITO'Neill Gilmore Neil
CEO
1,036,864$01,036,864
(Direct)
View
2022-05-26
Option Award
2022-05-31
4:32 pm
N/A
2032-05-25
Aptinyx Inc.APTXO'Neill Gilmore Neil
Director
40,000$040,000
(Direct)
View
2021-10-19
Option Award
2021-10-22
4:19 pm
N/A
2031-10-18
Aptinyx Inc.APTXO'Neill Gilmore Neil
Director
80,000$080,000
(Direct)
View
2021-06-24
Option Award
2021-06-28
5:26 pm
N/A
2031-06-23
Unity Biotechnology Inc.UBXO'Neill Gilmore Neil
Director
13,425$013,425
(Direct)
View
2021-02-28
Tax Withholding(A)
2021-03-10
8:02 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
524$86.9728,546
(Direct)
View
2021-03-03
Option Award(A)
2021-03-10
8:02 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
15,000$028,546
(Direct)
View
2021-03-03
Option Award
2021-03-05
8:05 pm
2022-03-03
2031-03-03
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
75,000$089,070
(Direct)
View
2020-12-10
Option Award
2020-12-14
5:16 pm
N/A
2030-12-09
Unity Biotechnology Inc.UBXO'Neill Gilmore Neil
Director
50,000$050,000
(Direct)
View

Ownership
2020-12-14
5:10 pm
N/A
2030-06-17
Unity Biotechnology Inc.UBXO'Neill Gilmore Neil
Director
0$040,000
(Direct)
View
2020-02-28
Option Award
2020-02-28
8:02 pm
N/A
2030-02-28
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
44,200$051,570
(Direct)
View
2019-05-23
Exercise
2019-05-24
8:07 pm
2019-05-23
N/A
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
12,000$07,370
(Direct)
View
2019-05-24
Tax Withholding
2019-05-24
8:07 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
4,630$119.317,370
(Direct)
View
2019-03-04
Option Award
2019-03-04
8:09 pm
N/A
2029-03-04
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
EVP, R&D & CMO
55,000$055,000
(Direct)
View
2018-06-07
Option Award
2018-06-11
6:11 pm
N/A
2028-06-07
Sarepta Therapeutics Inc.SRPTO'Neill Gilmore Neil
SVP & Chief Medical Officer
112,000$0112,000
(Direct)
View
(A) Indicate amendment filing.